Symposia

Below you can find the program of the industry - supported symposia, held at the 3rd CEE Meeting on Viral Hepatitis and Co-infection with HIV.

On the path to elimination: From Clinical Trials to Real World

Wednesday, 27 September 2017, 14.00 - 15.00 | Supported by MSD 

  • Introduction | Heiner Wedemeyer, MD, Germany
  • Lessons Learned from Real World Experience | Heiner Wedemeyer, MD, Germany
  • Treating Today’s Populations at Risk | Martin Kåberg, MD, Sweden
  • Treatment of HCV: the Slovenian example | Mojca Maticic, MD, PhD,  Slovenia
  • Q&A and Closing Remarks | Heiner Wedemeyer, MD, Germany

Download the Flyer 

_____________________________________________________________________

HCV in high risk and HIV/HCV co-infected populations : a personal and public health perspective

Wednesday, 27 September 2017, 17.15 - 18.15 | Supported by AbbVie

  • Overview of HCV infection in high-risk populations  | Mojca Matičič
  • HIV/HCV-co-infected patients: key considerations in therapeutic management | Andrew Ustianowski
  • HCV and drug-drug interactions in high risk populations. | David Back

_____________________________________________________________________

Going beyond together: evolving HCV care

Thursday, 28 September 2017, 8.30 - 9.30 | Supported by Gilead Sciences

  • The need to evolve HCV care  | Mojca Matičič
  • Evolving HCV screening and linkage to care | Marieta Simonova
  • Evolving HCV treatment | Béla Hunyady
  • Going beyond together for all patients with HCV | Mojca Matičič

Download the Flyer